Page 7 - Accelerate Diagnostics News Today

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 4,760,000 shares, a decline of 6.1% from the March 15th total of 5,070,000 shares. Based on an average daily volume of 293,900 shares, the short-interest ratio is […]

Global Antibiotic Resistance Diagnostic Market

Operator: Good afternoon, and welcome to the Accelerate Diagnostics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.

TUCSON, Ariz. — TUCSON, Ariz. — Accelerate Diagnostics Inc. (AXDX) on Wednesday reported a loss of $14.8 million in its fourth quarter. The Tucson,…

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022. "In...

TUCSON, Ariz., March 29, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022. ...

Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, March 29th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Accelerate Diagnostics Stock Up […]

Read user reviews, compare products & request pricing from manufacturers of Immunology Analyzers | Immunology

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling...

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 29, 2023, at 4:30 p....